Free Radical Research Center

Print Page Print   EmailEmail   Bookmark Page Bookmark   RSS Feeds RSS

2007 Publications of the Free Radical Research Center

  1. Bubolz AH, Wu Q, Larsen BT, Gutterman DD, Liu Y. Ebselen Reduces Nitration and Restores Voltage-gated Potassium Channel Function in Small Coronary Arteries of Diabetic Rats. Am. J. Physiol Heart Circ. Physiol 293(4): 2231-2237, 2007.  Abstract

  2. Hoch AZ, Jurva JW, Staton MA, Thielke R, Hoffmann RG, Gutterman DD, Pajewski N. Athletic Amenorrhea and Endothelial Dysfunction WMJ 106(6) 301:306, 2007.  Abstract

  3. Larsen BT, Zhang DX, Gutterman DD. Epoxyeicosatrienoic Acids, TRP Channels, and Intracellular Ca2+ in the Vasculature: An Endothelium-Derived Endothelium Hyperpolarizing Factor? Arterioscler. Thromb. Vasc. Biol 27: 2496-2498, 2007. 

  4. Hoch AZ, Lal S, Jurva JW, Gutterman DD. The Female Athlete Triad and Cardiovascular Dysfunction Phys. Med .Rehabil. Clin. N. Am. 18(3):385-viii, 2007.  Abstract

  5. Zhang DX, Gutterman DD. Mitochondrial Reactive Oxygen Species-Mediated Signaling in Endothelial Cells. Am. J. Physiol Heart Circ. Physiol 292(5): 2023-2031, 2007.  Abstract

  6. Pagano PJ, Gutterman DD. The Adventitia: The Outs and Ins of Vascular Disease. Cardiovascular Research 75:636-639, 2007.

  7. Gutterman DD. Combating Nitrate Tolerance – A Novel Endogenous Mechanism. Arterioscler. Thromb. Vasc. Biol. 27:1673-1676, 2007.

  8. Larsen BT, Campbell WB, Gutterman DD. Beyond vasodilatation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system. Trends Pharmacol Sci. 28:32-8, 2007.  Abstract

     
  9. Sarközi R, Miller B, Pollack V, Feifel F, Mayer G, Sorokin A, Schramek H.  ERK1/2-driven and MKP-mediated inhibition of EGF-induced ERK5 signaling in human proximal tubular cells. J. Cellul. Physiol. 211: 88-100, 2007
     
  10. Yang C, Patel K, Harding P, Sorokin A, Glass WF 2nd. Regulation of TGF-beta1/MAPK-mediated PAI-1 gene expression by the actin cytoskeleton in human mesangial cells. Exp.Cell Res. 313:1240-1250, 2007
     
  11. Moriyama T, Marquez JP, Wakatsuki T, Sorokin A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J.Virol. 81:8552-8562, 2007.  Abstract
     
  12. Yang M, Kroft SH, Chitambar CR. Gene expression analysis of gallium-resistant and –sensitive lymphoma cells reveals a role for metal-responsive transcription factor-1, metallothionein-2A, and zinc transporter-1 in modulating the antineoplastic activity of gallium nitrate. Molecular Cancer Therapeutics. 6:633-43, 2007.  Abstract
     
  13. Bommakanti S, Patil A, Eshoa C, Chitambar CR. Efalizumab-associated lymphoproliferative disease. Journal of Drugs in Dermatology: 6:25-27, 2007.  Abstract
     
  14. Chitambar CR, Purpi DP, Woodliff J, Yang M, Wereley JP. Gallium maltolate: a novel hydroxypyrone gallium compound with antineoplastic activity against lymphoma cells resistant to gallium nitrate. Journal of Pharmacology and Experimental Therapeutics, 322:122-1236, 2007.  Abstract
     
  15. Khanna AK, Pieper GM. NADPH oxidase subunits (NOX-1, p22phox, Rac-1) and tacrolimus-induced nephrotoxicity in a rat renal transplant model. Nephrol. Dial. Transplant. 22: 376-385, 2007.  Abstract
     
  16. Nilakantan V, Hilton G, Maenpaa C, Van Why S, Pieper GM, Johnson CP, Shames BD. Favorable balance of anti-oxidant/pro-oxidant systems and ablated oxidative stress in Brown Norway rats in renal ischemia-reperfusion injury. Mol. Cell. Biochem. 304:1-11, 2007.  Abstract
     
  17. Newman PJ, Newman DK. Functions of PECAM-1 in the Vascular Endothelium. In Endothelial Biomedicine (WC Aird, editor), Cambridge University Press, New York, NY, pp. 1037-48, 2007.
     
  18. Rathore VB, Okada M, Newman PJ, Newman DK. Paxillin family members function as Csk binding proteins that regulate Lyn activity in human and murine platelets. Biochemical Journal 403:275-81, 2007.  Abstract
     
  19. Machida K, Thompson CM, Dierck K, Jablonowski K, Karkkainen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, Pawson T, Renkema GH, Saksela K, Schiller M, Shin D-G, Mayer BJ. High-throughput phosphotyrosine profiling using SH2 domains. Molecular Cell 26:899-915, 2007.
     
  20. Goel R, Boylan B, Gruman L, Newman PJ, North P, Newman DK. The proinflammatory phenotype of PECAM-1-deficient mice results in atherogenic diet-induced steatohepatitis. Am. J. Physiol. Gastrointest. Liver Physiol. 293:G1205-14, 2007.
     
  21. Strande JL, Hsu A, Su J, Fu X, Gross GJ, Baker JE. SCH 79797, a selective PAR-1 antagonist, limits myocardial ischemia-reperfusion injury in rat hearts. Basic Res Cardiol 102:350-358, 2007.
     
  22. Baker JE, Kozik D, Hsu AK, Fu X, Tweddell JS, Gross GJ.  Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action and mechanisms. J Cardiovasc Pharmacol 49:337-345, 2007.
     
  23. Shi Y, Jiang MT, Su J, Hutchins W, Konorev E, Baker JE. Mitochondrial big conductance KCa channel and cardioprotection in infant rabbit heart. J Cardiovasc Pharmacol 50:497-502, 2007.
     
  24. Baker JE, Su J, Fu X, Hsu A, Gross GJ, Tweddell JS, Hogg N. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and KATP channels. J Mol Cell Cardiol 43:437-444, 2007.
      
  25. Borthiry GR, Antholine WE, Kalyanaraman B, Myers JM, Myers CR. Reduction of hexavalent chromium by human cytochrome b5: generation of hydroxyl radical and superoxide. Free Radic. Biol. Med. 42:738–755, 2007. Published with a commentary because the manuscript was ranked as exceptional and a "hot" topic.
     
  26. Rademacher DJ, Hillard CJ. Interactions between endocannabinoids and stress-induced decreased sensitivity to natural reward. Prog Neuropsychopharmacol Biol Psychiatry 31:633-41, 2007.  Abstract
     
  27. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN. Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 autoreactive T cells. Nature Med. 13: 492-497, 2007.
     
  28. Benito C, Romero JP, Tolon RM, Hillard CJ, Guaza C, Romero J. Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque-associated cells in human multiple sclerosis. J. Neurosci. 27: 2396-402, 2007.  Abstract
     
  29. Hill MN, Barr AM, Ho W-S V, Carrier EJ, Gorzalka BB, Hillard CJ. Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity. J. Neurochem. 103: 47-56, 2007.  Abstract
     
  30. Hillard CJ, Ho W-S V, Thompson J, Gauthier KM, Wheelock CE, Huang H, Hammock BD. Effects of catabolic inhibitors in vasodilation of rat middle cerebral artery by the endocannabinoid, 2-arachidonylglycerol. Brit. J. Pharmacol. 152:691-698, 2007.  Abstract
     
  31. Hillard CJ, Shi L, Tuniki VR, Falck JR, Campbell WB. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase. J. Mol. Neurosci. 33:18-24, 2007.  Abstract
     
  32. Hamilton JA, Hillard CJ, Spector AA, Watkins PA. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. J. Mol. Neurosci. 33:2-11, 2007.  Abstract
     
  33. Katz R, Hamilton JA, Pownall HJ, Deckelbaum RJ, Hillard CJ, Leboeuf RC, Watkins PA. Brain uptake and utilization of Fatty acids, lipids & lipoproteins: recommendations for future research. J. Mol. Neurosci. 33:146-50, 2007.  Abstract 
webmaster@mcw.edu
© 2007 Medical College of Wisconsin
Page Updated 05/06/2008